Ryan Finn, MD
Pain Medicine · St Louis Park, MNNPI 1558898684
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,670 of the $5,248 with a category attached, or 69.9%. 7 manufacturers reported payments, led by Boston Scientific at 30.4% of the total. 2025 is the largest year on record at $2,054, more than ten times the $90 reported in 2019.
Across 59 payments — averaging $88.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Abbott$1K
- Medtronic$1K
- Si-bone, Inc.$842
- Nevro Corp.$140
- Stryker$26
- plus $20 from 1 others
What the payments were for
- Travel & lodging$3,67070%
- Food & beverage$1,57930%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 12 | $1,595 |
| Abbott | 21 | $1,430 |
| Medtronic | 13 | $1,194 |
| Si-bone, Inc. | 7 | $842 |
| Nevro Corp. | 4 | $140 |
| Stryker | 1 | $26 |
| Vertos Medical, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$1,009
- SPECTRA WAVEWRITER$913
- PROCLAIM$823
- IFUSE IMPLANT SYSTEM$665
- Intracept$171
- Proclaim IPG$110
How this compares
$5,248 in reported general payments places this provider in the 70th percentile of 88 pain medicine providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 16 | $9,440 |
| SavellaMilnacipran Hcl | 11 | $7,864 |
| Duloxetine Hcl | 176 | $4,028 |
| Pregabalin | 89 | $3,624 |
| Gabapentin | 166 | $2,791 |
| Baclofen | 11 | $483 |
| Tizanidine Hcl | 43 | $289 |
| Tramadol Hcl | 32 | $202 |
| Topiramate | 37 | $177 |
| Methocarbamol | 16 | $167 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $147 |
| Hydromorphone Hcl | 18 | $127 |
| Oxycodone Hcl | 25 | $66 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in St Louis Park
- Brandon SmithSt Louis Park$2K
- Babatunde AdekolaSt Louis Park$2K
- Richard StaynerEdina$105K
- David SchultzEdina$99K
- Jonathan HagedornRochester$83K
- Michael McEntireRochester$70K
- Ronald BoedingMaple Grove$68K
- Matthew ThorsonEdina$59K
- Sherri HaasEdina$51K
- Cody FosterCoon Rapids$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.